Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of sGC stimulators for the treatment of nonalcoholic steatohepatitis (NASH)

Use of sGC stimulators for the treatment of nonalcoholic steatohepatitis (NASH)

US Patent 11357777 · Granted Jun 14, 2022

Estimated economic value: $449,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

2,6,9-trisubstituted purines2025
sGC stimulators2025
sGC stimulators2025
Oligonucleotides for the treatment of nucleotide repeat expansion disorders asso2025
sGC stimulators2024
SGC stimulators2023
Oligonucleotides for the treatment of nucleotide repeat expansion disorders asso2022
sGC stimulators2021
sGC stimulators2021
sGC stimulators2021
sGC stimulators2021
SGC stimulators2021